Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

An adverse reaction to the herbal medication milk thistle (Silybum marianum). Adverse Drug Reactions Advisory Committee.

[No authors listed]

Med J Aust. 1999 Mar 1;170(5):218-9. No abstract available.

PMID:
10092919
2.

Advances in the use of milk thistle (Silybum marianum).

Post-White J, Ladas EJ, Kelly KM.

Integr Cancer Ther. 2007 Jun;6(2):104-9. Review.

PMID:
17548789
3.

A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.

Smith WA, Lauren DR, Burgess EJ, Perry NB, Martin RJ.

Planta Med. 2005 Sep;71(9):877-80.

PMID:
16206045
4.

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):275-80.

PMID:
16460486
5.

Milk thistle (Silybum marianum) for the therapy of liver disease.

Flora K, Hahn M, Rosen H, Benner K.

Am J Gastroenterol. 1998 Feb;93(2):139-43. Review.

PMID:
9468229
6.

Milk thistle: Silybum marianum.

Pepping J.

Am J Health Syst Pharm. 1999 Jun 15;56(12):1195-7. No abstract available.

PMID:
10484652
7.

Silybum marianum (milk thistle).

[No authors listed]

Altern Med Rev. 1999 Aug;4(4):272-4. No abstract available.

8.

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.

Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M.

Phytother Res. 2006 Dec;20(12):1036-9.

PMID:
17072885
9.

Silymarin BIO-C, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats.

Capasso R, Aviello G, Capasso F, Savino F, Izzo AA, Lembo F, Borrelli F.

Phytomedicine. 2009 Sep;16(9):839-44. doi: 10.1016/j.phymed.2009.02.007. Epub 2009 Mar 20.

PMID:
19303749
10.

Milk thistle and the treatment of hepatitis.

Giese LA.

Gastroenterol Nurs. 2001 Mar-Apr;24(2):95-7. Review.

PMID:
11847735
11.

Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).

Tamayo C, Diamond S.

Integr Cancer Ther. 2007 Jun;6(2):146-57. Review.

PMID:
17548793
13.

Silyamandin, a new flavonolignan isolated from milk thistle tinctures.

MacKinnon SL, Hodder M, Craft C, Simmons-Boyce J.

Planta Med. 2007 Sep;73(11):1214-6. Epub 2007 Sep 7.

PMID:
17823870
14.

Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.

Piscitelli SC, Formentini E, Burstein AH, Alfaro R, Jagannatha S, Falloon J.

Pharmacotherapy. 2002 May;22(5):551-6.

PMID:
12013352
15.

[Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].

De Martiis M, Fontana M, Assogna G, D'Ottavi R, D'Ottavi O.

Clin Ter. 1980 Aug 15;94(3):283-315. Italian. No abstract available.

PMID:
7004762
16.

Future directions for research on Silybum marianum for cancer patients.

Sagar SM.

Integr Cancer Ther. 2007 Jun;6(2):166-73. Review.

PMID:
17548795
17.

["Silymarin"--an extract from the milk thistle (Silybum marianum)--is it a drug or nutritional supplement?].

Simánek V, Walterová D, Vicar J, Urbaníková J, Kren V, Modrianský M, Skottová N, Ulrichová J.

Ceska Slov Farm. 2001 Mar;50(2):66-9. Czech.

PMID:
11288592
18.

Silybin and silymarin--new effects and applications.

Kren V, Walterová D.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):29-41. Review.

19.

Variability pattern and correlation studies in Silybum marianum Gaertn.

Ram G, Bhan MK, Gupta KK, Thaker B, Jamwal U, Pal S.

Fitoterapia. 2005 Mar;76(2):143-7. Epub 2005 Jan 26.

PMID:
15752622
20.

Low dose methotrexate therapy--toxic if not taken correctly. Adverse Drug Reactions Advisory Committee.

[No authors listed]

Med J Aust. 1994 Jul 18;161(2):152. No abstract available.

PMID:
8028541

Supplemental Content

Support Center